【表紙】 

 

【提出書類】

四半期報告書

【根拠条文】

金融商品取引法第24条の4の7第1項

【提出先】

関東財務局長

【提出日】

2024年5月13日

【四半期会計期間】

第186期第1四半期(自  2024年1月1日  至  2024年3月31日)

【会社名】

キリンホールディングス株式会社

【英訳名】

Kirin Holdings Company, Limited

【代表者の役職氏名】

代表取締役社長COO    南  方  健  志

【本店の所在の場所】

東京都中野区中野四丁目10番2号

【電話番号】

03(6837)7015

【事務連絡者氏名】

財務戦略部長  松  尾  英  史

【最寄りの連絡場所】

東京都中野区中野四丁目10番2号

【電話番号】

03(6837)7015

【事務連絡者氏名】

財務戦略部長  松  尾  英  史

【縦覧に供する場所】

株式会社東京証券取引所

(東京都中央区日本橋兜町2番1号)

 

 

E00395 25030 キリンホールディングス株式会社 Kirin Holdings Company, Limited 企業内容等の開示に関する内閣府令 第四号の三様式 IFRS true cte 2024-01-01 2024-03-31 Q1 2024-12-31 2023-01-01 2023-03-31 2023-12-31 1 false false false E00395-000 2024-05-13 E00395-000 2024-05-13 jpcrp_cor:OrdinaryShareMember E00395-000 2024-03-31 E00395-000 2024-03-31 jpigp_cor:CapitalSurplusIFRSMember E00395-000 2024-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember E00395-000 2024-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember E00395-000 2024-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember E00395-000 2024-03-31 jpigp_cor:NetChangeInFairValueOfEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember E00395-000 2024-03-31 jpigp_cor:NonControllingInterestsIFRSMember E00395-000 2024-03-31 jpcrp_cor:OrdinarySharesSharesLessThanOneUnitMember E00395-000 2024-03-31 jpcrp_cor:OrdinarySharesSharesWithFullVotingRightsOtherMember E00395-000 2024-03-31 jpcrp_cor:OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember E00395-000 2024-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember E00395-000 2024-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember E00395-000 2024-03-31 jpigp_cor:RetainedEarningsIFRSMember E00395-000 2024-03-31 jpcrp_cor:Row1Member E00395-000 2024-03-31 jpigp_cor:ShareCapitalIFRSMember E00395-000 2024-03-31 jpcrp_cor:SharesWithNoVotingRightsMember E00395-000 2024-03-31 jpcrp_cor:SharesWithRestrictedVotingRightsOtherMember E00395-000 2024-03-31 jpcrp_cor:SharesWithRestrictedVotingRightsTreasurySharesEtcMember E00395-000 2024-03-31 jpigp_cor:TreasurySharesIFRSMember E00395-000 2024-01-01 2024-03-31 E00395-000 2024-01-01 2024-03-31 jpigp_cor:CapitalSurplusIFRSMember E00395-000 2024-01-01 2024-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember E00395-000 2024-01-01 2024-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember E00395-000 2024-01-01 2024-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember E00395-000 2024-01-01 2024-03-31 jpcrp040300-q1r_E00395-000:AlcoholicBeveragesReportableSegmentMember E00395-000 2024-01-01 2024-03-31 jpcrp040300-q1r_E00395-000:HealthScienceReportableSegmentMember E00395-000 2024-01-01 2024-03-31 jpcrp040300-q1r_E00395-000:NonAlcoholicBeveragesReportableSegmentMember E00395-000 2024-01-01 2024-03-31 jpcrp040300-q1r_E00395-000:PharmaceuticalsReportableSegmentMember E00395-000 2024-01-01 2024-03-31 jpigp_cor:NetChangeInFairValueOfEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember E00395-000 2024-01-01 2024-03-31 jpigp_cor:NonControllingInterestsIFRSMember E00395-000 2024-01-01 2024-03-31 jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember E00395-000 2024-01-01 2024-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember E00395-000 2024-01-01 2024-03-31 jpcrp_cor:ReconcilingItemsMember E00395-000 2024-01-01 2024-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember E00395-000 2024-01-01 2024-03-31 jpigp_cor:RetainedEarningsIFRSMember E00395-000 2024-01-01 2024-03-31 jpigp_cor:ShareCapitalIFRSMember E00395-000 2024-01-01 2024-03-31 jpigp_cor:TreasurySharesIFRSMember E00395-000 2023-03-31 E00395-000 2023-03-31 jpigp_cor:CapitalSurplusIFRSMember E00395-000 2023-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember E00395-000 2023-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember E00395-000 2023-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember E00395-000 2023-03-31 jpigp_cor:NetChangeInFairValueOfEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember E00395-000 2023-03-31 jpigp_cor:NonControllingInterestsIFRSMember E00395-000 2023-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember E00395-000 2023-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember E00395-000 2023-03-31 jpigp_cor:RetainedEarningsIFRSMember E00395-000 2023-03-31 jpigp_cor:ShareCapitalIFRSMember E00395-000 2023-03-31 jpigp_cor:TreasurySharesIFRSMember E00395-000 2023-01-01 2023-12-31 E00395-000 2023-12-31 E00395-000 2023-12-31 jpigp_cor:CapitalSurplusIFRSMember E00395-000 2023-12-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember E00395-000 2023-12-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember E00395-000 2023-12-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember E00395-000 2023-12-31 jpigp_cor:NetChangeInFairValueOfEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember E00395-000 2023-12-31 jpigp_cor:NonControllingInterestsIFRSMember E00395-000 2023-12-31 jpigp_cor:OtherComponentsOfEquityIFRSMember E00395-000 2023-12-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember E00395-000 2023-12-31 jpigp_cor:RetainedEarningsIFRSMember E00395-000 2023-12-31 jpigp_cor:ShareCapitalIFRSMember E00395-000 2023-12-31 jpigp_cor:TreasurySharesIFRSMember E00395-000 2023-01-01 2023-03-31 E00395-000 2023-01-01 2023-03-31 jpigp_cor:CapitalSurplusIFRSMember E00395-000 2023-01-01 2023-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember E00395-000 2023-01-01 2023-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember E00395-000 2023-01-01 2023-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember E00395-000 2023-01-01 2023-03-31 jpcrp040300-q1r_E00395-000:AlcoholicBeveragesReportableSegmentMember E00395-000 2023-01-01 2023-03-31 jpcrp040300-q1r_E00395-000:HealthScienceReportableSegmentMember E00395-000 2023-01-01 2023-03-31 jpcrp040300-q1r_E00395-000:NonAlcoholicBeveragesReportableSegmentMember E00395-000 2023-01-01 2023-03-31 jpcrp040300-q1r_E00395-000:PharmaceuticalsReportableSegmentMember E00395-000 2023-01-01 2023-03-31 jpigp_cor:NetChangeInFairValueOfEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember E00395-000 2023-01-01 2023-03-31 jpigp_cor:NonControllingInterestsIFRSMember E00395-000 2023-01-01 2023-03-31 jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember E00395-000 2023-01-01 2023-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember E00395-000 2023-01-01 2023-03-31 jpcrp_cor:ReconcilingItemsMember E00395-000 2023-01-01 2023-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember E00395-000 2023-01-01 2023-03-31 jpigp_cor:RetainedEarningsIFRSMember E00395-000 2023-01-01 2023-03-31 jpigp_cor:ShareCapitalIFRSMember E00395-000 2023-01-01 2023-03-31 jpigp_cor:TreasurySharesIFRSMember E00395-000 2022-12-31 E00395-000 2022-12-31 jpigp_cor:CapitalSurplusIFRSMember E00395-000 2022-12-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember E00395-000 2022-12-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember E00395-000 2022-12-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember E00395-000 2022-12-31 jpigp_cor:NetChangeInFairValueOfEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember E00395-000 2022-12-31 jpigp_cor:NonControllingInterestsIFRSMember E00395-000 2022-12-31 jpigp_cor:OtherComponentsOfEquityIFRSMember E00395-000 2022-12-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember E00395-000 2022-12-31 jpigp_cor:RetainedEarningsIFRSMember E00395-000 2022-12-31 jpigp_cor:ShareCapitalIFRSMember E00395-000 2022-12-31 jpigp_cor:TreasurySharesIFRSMember iso4217:JPY iso4217:JPY xbrli:shares xbrli:pure xbrli:shares